<DOC>
	<DOCNO>NCT01658306</DOCNO>
	<brief_summary>The hypothesis study remote ischemic preconditioning ( RIPC ) might beneficial effect outcomes cerebral small vessel disease ( CSV ) .</brief_summary>
	<brief_title>Clinical Trial Remote Ischemic Preconditioning Cerebral Small Vessel Disease</brief_title>
	<detailed_description>CSV constitute important type ischemic stroke due generalize hypo-perfusion brain . Few treatment method available except beneficial effect show nimodipine . The potential treatment effect RIPC protection brain cerebral small vessel disease investigate . The investigator design randomize , double-blind , control clinical trial examine ( 1 ) whether RIPC beneficial effect brain lesion CSV , ( 2 ) whether RIPC protect patient CSV cognitive deterioration . There 2 arm trial : One arm RIPC treatment , one sham RIPC treatment . Brain lesion quantify volumetric MRI , Xe-CT use evaluate cerebral blood perfusion . Cognitive function evaluate mini-mental state examination ( MMSE ) Montreal Cognitive Assessment ( MoCA ) .</detailed_description>
	<mesh_term>Cerebral Small Vessel Diseases</mesh_term>
	<criteria>1 . Subjects age 4080 year ; 2 . Ischemic cerebrovascular event onset , , must within 6 month ; 3 . TCD carotid ultrasound exclude vascular narrow cause hemodynamic change ( usually &gt; 50 % narrow lumen ) ; 4 . MRI confirm presence lacunar infarction / generalize white matter lesion ; 5 . Written consent obtain subject . 1 . History intracranial hemorrhage ; 2 . Significant bleeding part body ; 3 . History atrial fibrillation ; 4 . History myocardial infarction within six month ; 5 . Moyamoya disease vasculitis ; 6 . Hereditary small vessel disorder , CADASIL , FABRY , mitochondrial encephalomyopathy ; 7 . Significant bleedingcoagulation dysfunction ; 8 . Abnormal blood pressure , glucose and/or lipid restrict treatment regimen ; 9 . Severe liver/kidney disease , cancer critical illness internal medicine surgery .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>remote ischemic preconditioning</keyword>
	<keyword>random-controlled</keyword>
	<keyword>double blind</keyword>
	<keyword>RIPC</keyword>
</DOC>